# Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)

> **NCT02417974** · PHASE2 · TERMINATED · sponsor: **Boston Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplant (FMT)

## Key facts

- **NCT ID:** NCT02417974
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2021-02-04
- **Final completion:** 2021-02-04
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Low enrollment was exacerbated by a covid policy related study suspension so the research was stopped.
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417974, "Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02417974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*